Technique And Results In Endothelial Keratoplasty
TREK
Technique And Results Evaluation In Endothelial Keratoplasty
1 other identifier
interventional
62
1 country
1
Brief Summary
To assess and compare the complications and results of different lamellar endothelial keratoplasty techniques and its variations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2014
CompletedFirst Submitted
Initial submission to the registry
June 6, 2015
CompletedFirst Posted
Study publicly available on registry
June 12, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2021
CompletedMarch 11, 2021
March 1, 2021
6.3 years
June 6, 2015
March 9, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Visual acuity
First six months postoperatively
Secondary Outcomes (3)
Endothelial cell density
First six months postoperatively
Intraoperative complications
First six months postoperatively
Postoperative complications
First six months postoperatively
Study Arms (2)
DSAEK group
ACTIVE COMPARATORSubjects operated of Descemet Stripping Automated Endothelial Keratoplasty.
DMEK group
EXPERIMENTALSubjects operated of Descemet Membrane Endothelial Keratoplasty.
Interventions
Descemet Stripping Automated Endothelial Keratoplasty
Descemet Membrane Endothelial Keratoplasty
Eligibility Criteria
You may qualify if:
- Diagnosis with corneal endothelial dysfunction requiring lamellar endothelial corneal transplantation.
- Free acceptance to be enrolled in the trial, and signature of the informed consent by the subject and/or its legal representatives.
You may not qualify if:
- N/A
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Universitari Mutua Terrassa
Terrassa, Barcelona, 08221, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eduard Pedemonte-Sarrias, MD
Hospital Universitari Mútua Terrassa
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- MEDICAL DOCTOR
Study Record Dates
First Submitted
June 6, 2015
First Posted
June 12, 2015
Study Start
September 1, 2014
Primary Completion
January 1, 2021
Study Completion
January 1, 2021
Last Updated
March 11, 2021
Record last verified: 2021-03